Common TitleSURVEYOR-II (Part 3)
Official Title Glecaprevir/Pibrentasvir for HCV Genotype 3 Patients with Cirrhosis and/or Prior Treatment Experience: A Partially Randomized Phase III Clinical Trial.
Phase Phase III
ClinicalTrials.gov NCT02243293
Treatments
Glecaprevir-Pibrentasvir
Glecaprevir-Pibrentasvir
Tradename:MavyretOther Names:GLE-PIBClass:FDA-ApprovedFunding
IndustryAbbVie